Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | CETP | P11597 | 5/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9565686 | 0.98 | CYP2C19 (0.54) | CYP2C19CETPTBXAS1CYP4F2CYP4A11 | |
| SCHEMBL4277564 | 0.98 | CYP2C19 (0.52) | CYP2C19CETPTBXAS1CYP4F2CYP4A11 | |
| SCHEMBL4580987 | 0.93 | CYP2C19 (0.46) | CYP2C19CETPTBXAS1CYP4F2CYP4A11 | |
| SCHEMBL3153596 | 0.88 | — | — | |
| SCHEMBL887668 | 0.87 | CYP2C19 (0.52) | CYP2C19CETPTBXAS1CYP4F2CYP4A11 | |
| SCHEMBL11293143 | 0.87 | CYP2C19 (0.52) | CYP2C19CETPTBXAS1CYP4F2CYP4A11 | |
| Hydrochloric Acid SCHEMBL11613521 | 0.86 | CYP2C19 (0.38) | CYP2C19CETPTBXAS1MMEFFAR3 | |
| SCHEMBL9180415 | 0.85 | CYP2C19 (0.65) | CYP2C19TBXAS1CYP4F2CYP4A11MME | |
| SCHEMBL9183557 | 0.85 | CYP2C19 (0.65) | CYP2C19TBXAS1CYP4F2CYP4A11MME | |
| SCHEMBL887729 | 0.85 | CYP2C19 (0.50) | CYP2C19CETPTBXAS1CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110511539-A | The polymer dispersed liquid crystal layer and preparation method thereof of polyether diamine mixture cured epoxy | HUBEI XIONGHUA TECH CO LTD | 2019-11-29 | — | — | CN | claimed |
| EP-0025119-B1 | NEMATIC CRYSTALLINE-LIQUID 5-ALKYL-2-(4-ACYLOXYPHENYL)-PYRIMIDINES FOR OPTO-ELECTRONIC ARRANGEMENTS AND PROCESS FOR THEIR PREPARATION | VEB Werk Für Fernsehelektronik im VEB Kombinat Mikroelektronik (DD) | 1983-05-25 | — | — | EP | claimed |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | RESONAC CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4692041-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | ADEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20250387833-A1 | METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE | RESONAC CORP (JP) | 2025-12-25 | — | — | US | disclosed |
| US-20250293091-A1 | METHOD FOR PRODUCING SUBSTRATE HAVING THROUGH-SILICON VIAS, SUBSTRATE HAVING THROUGH-SILICON VIAS, AND COPPER PASTE FOR THROUGH-SILICON VIA FORMATION | RESONAC CORPORATION (JP) | 2025-09-18 | — | — | US | disclosed |
| EP-4618701-A1 | METHOD FOR MANUFACTURING GLASS SUBSTRATE HAVING CONDUCTIVE VIA, METAL PASTE FOR FORMING THROUGH-GLASS VIA, AND GLASS SUBSTRATE HAVING CONDUCTIVE VIA | Resonac Corporation (JP) | 2025-09-17 | — | — | EP | disclosed |
| US-12354914-B2 | Method for producing substrate having through-silicon vias, substrate having through-silicon vias, and copper paste for through-silicon via formation | RESONAC CORPORATION (JP) | 2025-07-08 | — | — | US | disclosed |
| EP-4551564-A2 | ONE-STEP SYNTHESIS OF BETA-ALKYLIDENE-GAMMA-LACTONES | The Scripps Research Institute (US) | 2025-05-14 | — | — | EP | disclosed |
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| CN-111283206-B | Copper paste for bonding, method for producing bonded body, and method for producing semiconductor device | 株式会社力森诺科 | 2024-11-26 | — | — | CN | disclosed |
| EP-0043185-A1 | Method for production of titanium halide catalyst component, catalyst system including such component, and polymerization of alpha-olefins using such system | STAUFFER CHEMICAL COMPANY (US) | 1982-01-06 | — | — | EP | disclosed |
| EP-0040711-A1 | Titanium halide catalyst for polymerization | STAUFFER CHEMICAL COMPANY (US) | 1981-12-02 | — | — | EP | disclosed |
| US-4296093-A | Cyclic carboxamides having a physiological cooling effect | WILKINSON SWORD LIMITED (GB) | 1981-10-20 | — | — | US | disclosed |
| US-4294948-A | Process for preparing olefin polymers or copolymers, and catalyst for use in said process | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1981-10-13 | — | — | US | disclosed |
| US-4283420-A | ANTICONVULSANTS, ANTIANAPHYLACTIC AGENTS, ANTIPSYCHOTIC AGENTS | LABAZ (FR) | 1981-08-11 | — | — | US | disclosed |
| EP-0023730-A1 | Cyclohexylcyclohexanoates, process for their preparation and liquid-crystal mixture containing them | MERCK PATENT GmbH (DE) | 1981-02-11 | — | — | EP | disclosed |
| US-4232139-A | Process for producing polymers or copolymers of olefins containing at least 3 carbon atoms | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1980-11-04 | — | — | US | disclosed |
| US-4221894-A | MAGNESIUM HALIDE, TITANIUM, ORGANOALUMINUM, ESTER | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1980-09-09 | — | — | US | disclosed |
| US-4143223-A | TITANIUM, HALOGEN, ALUMINUM, ESTER AND AN ALCOHOL | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1979-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387833-A1 | METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE | C5, C9, CUTA | CYP2C19 979/4885CETP 1026/4885TBXAS1 4583/4885 |
| US-12564879-B2 | Copper paste for joining, method for manufacturing joined body, and joined body | DCX, DNAJA2, DNAJA1 | CYP2C19 495/4885CETP 252/4885TBXAS1 2272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.